Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Apr 22:15:735-743.
doi: 10.2147/CCID.S359052. eCollection 2022.

Complementary Strategies to Promote Hair Regrowth in Post-COVID-19 Telogen Effluvium

Marius Nicolae Popescu  1 , Mihai Berteanu  1 , Cristina Beiu  2 , Liliana Gabriela Popa  2 , Mara Mădălina Mihai  2 , Madalina Gabriela Iliescu  3 , Ana Maria Alexandra Stănescu  4 , Anca Mirela Ionescu  5
Affiliations
Review

Complementary Strategies to Promote Hair Regrowth in Post-COVID-19 Telogen Effluvium

Marius Nicolae Popescu et al. Clin Cosmet Investig Dermatol. .

Abstract

Post-COVID-19 telogen effluvium has been largely reported as a sequela in the post-acute phase of COVID-19, causing major emotional distress among the affected patients. The affected individuals are further exposed to a vast amount of misinformation from the internet and social media and it is important for physicians to be familiar with the phenomenon and provide appropriate counselling to their patients regarding this condition. This article aims to review the evidence-based complementary strategies that can help enhance hair regrowth after post-COVID-19 hair loss, from psychological support and patient education to the importance of optimal nutrition and potential indications and benefits of oral nutritional supplementation, as well as the role of both topical and injectable hair growth stimulators.

Keywords: COVID-19; SARS-CoV-2; hair growth; hair loss; telogen effluvium.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Schematic representation of the complementary strategies that can help reduce post-COVID-19 hair loss and promote hair re-growth.
Figure 2
Figure 2
Acute reduction in total hair density in a 37-year-old female who is recovering from moderate SARS-CoV-2 infection. The diffuse hair loss is most noticeable in the frontotemporal region and first developed within two months after COVID-19. The patient also reported high levels of anxiety caused by the acute hair loss.
See this image and copyright information in PMC

References

    1. Olds H, Liu J, Luk K, Lim HW, Ozog D, Rambhatla PV. Telogen effluvium associated with COVID-19 infection. Dermatol Ther. 2021;34(2):e14761. doi:10.1111/dth.14761 - DOI - PMC - PubMed
    1. Sharquie KE, Jabbar RI. COVID-19 infection is a major cause of acute telogen effluvium. Ir J Med Sci. 2021. doi:10.1007/s11845-021-02754-5 - DOI - PMC - PubMed
    1. Christensen RE, Jafferany M. Association between alopecia areata and COVID-19: a systematic review. JAAD Int. 2022;7:57–61. doi:10.1016/j.jdin.2022.02.002 - DOI - PMC - PubMed
    1. Wambier CG, Vano-Galvan S, McCoy J, et al. Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: the “Gabrin sign”. J Am Acad Dermatol. 2020;83(2):680–682. doi:10.1016/j.jaad.2020.05.079 - DOI - PMC - PubMed
    1. Goren A, McCoy J, Wambier CG, et al. What does androgenetic alopecia have to do with COVID-19? An insight into a potential new therapy. Dermatol Ther. 2020;33(4):e13365. doi:10.1111/dth.13365 - DOI - PMC - PubMed